139 related articles for article (PubMed ID: 1703822)
21. Platelets, frozen plasma, and cryoprecipitate: what is the clinical evidence for their use in the neonatal intensive care unit?
Poterjoy BS; Josephson CD
Semin Perinatol; 2009 Feb; 33(1):66-74. PubMed ID: 19167583
[TBL] [Abstract][Full Text] [Related]
22. Platelet transfusion: future directions.
Slichter SJ
Vox Sang; 2004 Jul; 87 Suppl 2():47-51. PubMed ID: 15209878
[No Abstract] [Full Text] [Related]
23. A blood component program for the treatment of surgical haemorrhage and its potential for national supplies of albumin and factor VIII.
Lundsgaard-Hansen P
Haematologia (Budap); 1980; 13(1-4):155-67. PubMed ID: 6788660
[TBL] [Abstract][Full Text] [Related]
24. Bedside processing.
Krause KP
Vox Sang; 2004 Jul; 87 Suppl 2():76-8. PubMed ID: 15209884
[No Abstract] [Full Text] [Related]
25. [Directions for blood component therapy in blood coagulation disorders].
Rasche H
Klin Anasthesiol Intensivther; 1980; 21():136-51. PubMed ID: 6779052
[No Abstract] [Full Text] [Related]
26. [Preliminary experience with achieving immune tolerance in patients with hemophilia A and circulating factor VIII inhibitor].
Scharf R; Kucharski W; Lopaciuk S; Celińska W; Dmytrow A; Domański K; Gonet S; Miastkowski Z; Nowakowska I; Przybylski A
Acta Haematol Pol; 1991; 22(1):92-9. PubMed ID: 1823972
[TBL] [Abstract][Full Text] [Related]
27. Implementation of a strategy to prevent TRALI in a regional blood centre.
Insunza A; Romon I; Gonzalez-Ponte ML; Hoyos A; Pastor JM; Iriondo A; Hermosa V
Transfus Med; 2004 Apr; 14(2):157-64. PubMed ID: 15113380
[TBL] [Abstract][Full Text] [Related]
28. [Preparation-related effects on the coagulation activity of plasma].
Schmitt H
Beitr Infusionsther; 1989; 24():91-4. PubMed ID: 2481554
[TBL] [Abstract][Full Text] [Related]
29. [Experience with a blood component program in surgical hemotherapy].
Lundsgaard-Hansen P
Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(6):933-42. PubMed ID: 6187647
[TBL] [Abstract][Full Text] [Related]
30. [Blood component therapy after conversion to erythrocyte concentrate with added solutions].
Frey-Wettstein M
Beitr Infusionsther; 1990; 26():50-4. PubMed ID: 1703900
[TBL] [Abstract][Full Text] [Related]
31. [The status of blood component therapy in East Germany].
Fünfhausen G
Beitr Infusionsther; 1988; 21():354-6. PubMed ID: 2463009
[No Abstract] [Full Text] [Related]
32. Optimal use of blood components and derivatives.
Walter WJ; Oberman HA
Otolaryngol Clin North Am; 1981 Aug; 14(3):739-53. PubMed ID: 6795570
[No Abstract] [Full Text] [Related]
33. 12 simple sensible steps for successful blood transfusions.
Querin JJ; Stahl LD
Nursing; 1983 Nov; 13(11):34-43. PubMed ID: 6415556
[No Abstract] [Full Text] [Related]
34. [Thrombocyte preparation from whole blood stores. Data on yield and leukocyte contamination].
Mayer G; Wernet D; Schnaidt M; Sugg U
Beitr Infusionther Klin Ernahr; 1986; 15():66-74. PubMed ID: 3753415
[No Abstract] [Full Text] [Related]
35. [Occurrence of serum hepatitis following the administration of Cohn's fraction I or fibrinogen and antihemophilic globulin (AHG) respectively].
Fábryová L; Hrubisko M
Vnitr Lek; 1970 Feb; 16(2):123-6. PubMed ID: 5309309
[No Abstract] [Full Text] [Related]
36. New trends in blood component therapy.
Högman CF
Haematologia (Budap); 1983; 16(1-4):23-38. PubMed ID: 6383964
[No Abstract] [Full Text] [Related]
37. [The possibility of blood component therapy in Croatia (author's transl)].
Grgicević D; Bozović I; Pende B
Lijec Vjesn; 1981; 103(2-3):119-22. PubMed ID: 7311696
[No Abstract] [Full Text] [Related]
38. Update on pathogen reduction technology for therapeutic plasma: an overview.
Solheim BG; Seghatchian J
Transfus Apher Sci; 2006 Aug; 35(1):83-90. PubMed ID: 16934528
[TBL] [Abstract][Full Text] [Related]
39. Transfusion and Apheresis Science. Editorial 38.2.
Rock G
Transfus Apher Sci; 2008 Apr; 38(2):89. PubMed ID: 18400559
[No Abstract] [Full Text] [Related]
40. Plasma for fractionation: safety and quality issues.
Farrugia A
Haemophilia; 2004 Jul; 10(4):334-40. PubMed ID: 15230946
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
